HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interstitial granulomatous dermatitis successfully treated with etanercept.

AbstractPATIENT:
Female, 51 FINAL DIAGNOSIS: Interstitial Granulomatous Dermatitis Symptoms: Joint pain • pruritic rush
MEDICATION:
Etanercept Clinical Procedure: - Specialty: Rheumatology.
OBJECTIVE: BACKGROUND:
Interstitial granulomatous disease (IGD) is a rare skin condition that presents with erythematous and violaceous plaques, and may be associated with pruritus and pain. The cause remains unknown, but is often associated with autoimmune disease and drug-related adverse effects. It is diagnosed via biopsy, and the treatment remains unclear.
CASE REPORT:
We report a case of biopsy-proven IGD associated with rheumatoid arthritis that was treated successfully with etanercept therapy.
CONCLUSIONS:
We emphasize that anti-TNF antibodies may be clinically effective for the treatment of IGD.
AuthorsZavier Shawkat Ahmed, Sabaa Joad, Manpreet Singh, Sabiha S Bandagi
JournalThe American journal of case reports (Am J Case Rep) Vol. 15 Pg. 94-6 ( 2014) ISSN: 1941-5923 [Electronic] United States
PMID24624249 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: